The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval

EuroIntervention 2008;4:242-249 - DOI10.4244/EIJV4I2A43.

1. Thoraxcenter, Rotterdam, The Netherlands; 2. Seigburg Helios Heart Center, Seigburg, Germany; 3. Amphia Breda, Breda, The Netherlands; 4. Leipzig University Heart Center, Leipzig, Germany; 5. Graz Medical University Clinic, Graz, Austria; 6. Padova Hos

Aims: To describe the procedural performance and 30-day outcomes following implantation using the 18 Fr CoreValve Revalving System (CRS) as part of the multicentre, expanded evaluation regi

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement